{"nct_id":"NCT01127633","title":"Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease","status":"TERMINATED","status_verified_date":"2019-09","start_date":"2010-12","start_date_type":null,"primary_completion_date":"2014-07","primary_completion_date_type":"ACTUAL","completion_date":"2017-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}